Back to Search

ELIZABETH NUTI, MD

MD

Pediatrics Physician

NPI: 1609982875Individual

Specialties, Licenses & Credentials

Pediatrics PhysicianPrimary

Pediatrics

Code: 208000000X

A068426(CA)

Research & Publications (16)

N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.
PMID 19606871·J Med Chem·2009
8-other
Multitemplate alignment method for the development of a reliable 3D-QSAR model for the analysis of MMP3 inhibitors.
PMID 19522467·J Chem Inf Model·2009
8-other
Synthesis, SAR, and biological evaluation of alpha-sulfonylphosphonic acids as selective matrix metalloproteinase inhibitors.
PMID 19204958·ChemMedChem·2009
8-other
Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.
PMID 19053764·J Med Chem·2008
8-other
Fractal analysis of fluoroangiographic patterns in anterior ischaemic optic neuropathy and optic neuritis: a pilot study.
PMID 18700918·Clin Exp Ophthalmol·2008
8-other
Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors.
PMID 18640045·Bioorg Med Chem·2008
8-other
Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.
PMID 17719700·Eur J Med Chem·2008
7-preclinical
Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors.
PMID 17627541·Curr Pharm Des·2007
6-review
Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.
PMID 17276072·Bioorg Med Chem·2007
7-preclinical
Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.
PMID 17127067·Bioorg Med Chem·2007
8-other
alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.
PMID 17088065·Bioorg Med Chem·2007
8-other
Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides.
PMID 16483784·Bioorg Med Chem·2006
8-other
A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.
PMID 15837315·Bioorg Med Chem Lett·2005
8-other
N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.
PMID 15713379·Bioorg Med Chem Lett·2005
8-other
Synthesis and antimicrobial activity of new 7 beta-(benzo[a]dihydrocarbazolyloxyacetyl)-substituted cephalosporins.
PMID 15337434·Farmaco·2004
8-other
New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2).
PMID 15080939·Bioorg Med Chem·2004
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
NIGHT OWL PEDIATRICS 425 GREGORY LANE, SUITE 203
PLEASANT HILL, CA 94523

Location

Practice Location

NIGHT OWL PEDIATRICS 425 GREGORY LANE, PLEASANT HILL, CA
(925) 288-3600

Quick Facts

NPI
1609982875
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
16

Are you this provider?

Claim Your Profile